Corvus Pharmaceuticals logo
Corvus Pharmaceuticals CRVS
$ 6.14 5.32%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Corvus Pharmaceuticals EV/EBITDA Ratio 2011-2025 | CRVS

Annual EV/EBITDA Ratio Corvus Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.244 -2.16 -3.24 -1.41 -2.6 -5.74 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.244 -5.74 -2.49